Loading...
Header Logo
Keywords
Last Name

Concepts (78)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
16
2019
630
3.450
Why?
Radiosurgery
11
2019
323
2.030
Why?
Radiotherapy
1
2019
90
0.800
Why?
Hypoglycemic Agents
1
2018
198
0.710
Why?
Urinary Bladder Neoplasms
1
2018
106
0.680
Why?
Retrospective Studies
13
2019
2993
0.530
Why?
Cranial Irradiation
5
2019
90
0.530
Why?
Treatment Outcome
10
2019
3196
0.520
Why?
Aged
16
2019
9981
0.480
Why?
Middle Aged
17
2019
11485
0.470
Why?
Neuropsychological Tests
3
2019
429
0.460
Why?
Neoplasm Recurrence, Local
3
2018
321
0.440
Why?
Affective Symptoms
1
2009
14
0.440
Why?
Aged, 80 and over
9
2019
3920
0.440
Why?
Olfaction Disorders
1
2009
7
0.440
Why?
Parkinson Disease
1
2009
42
0.430
Why?
Salvage Therapy
3
2018
120
0.410
Why?
Radiotherapy, Conformal
2
2018
27
0.400
Why?
Male
17
2019
18665
0.370
Why?
Female
17
2019
18929
0.360
Why?
Humans
19
2019
29133
0.340
Why?
Follow-Up Studies
4
2018
2225
0.320
Why?
Lung Neoplasms
3
2019
470
0.310
Why?
Prognosis
6
2018
1439
0.310
Why?
Adult
9
2019
8615
0.290
Why?
Survival Rate
4
2018
858
0.280
Why?
Neoplasm Metastasis
2
2019
209
0.230
Why?
Radiotherapy, Adjuvant
2
2017
76
0.230
Why?
Multiple Sclerosis
1
2019
32
0.220
Why?
Small Cell Lung Carcinoma
1
2019
19
0.220
Why?
Trigeminal Neuralgia
1
2019
34
0.220
Why?
Disease Susceptibility
1
2019
47
0.210
Why?
Melanoma
2
2017
168
0.210
Why?
Maximum Tolerated Dose
1
2018
62
0.210
Why?
Prospective Studies
3
2019
2050
0.200
Why?
Costs and Cost Analysis
1
2018
89
0.200
Why?
Lymphatic Metastasis
1
2018
174
0.200
Why?
Genomics
1
2018
85
0.190
Why?
Meningeal Neoplasms
1
2017
44
0.190
Why?
Meningioma
1
2017
48
0.180
Why?
Medicare
1
2018
186
0.180
Why?
Survivors
1
2018
153
0.180
Why?
Glioblastoma
1
2018
153
0.170
Why?
Quality of Life
2
2019
856
0.170
Why?
Retroperitoneal Neoplasms
1
2015
11
0.170
Why?
Hippocampus
1
2017
201
0.160
Why?
Sarcoma
1
2015
42
0.160
Why?
Adenocarcinoma
1
2017
323
0.140
Why?
Smoking
1
2017
466
0.140
Why?
Disease Progression
3
2019
602
0.130
Why?
Young Adult
1
2018
2371
0.120
Why?
Neoplasms
1
2018
668
0.120
Why?
Psychiatric Status Rating Scales
1
2009
93
0.110
Why?
Smell
1
2009
49
0.100
Why?
Disease-Free Survival
2
2017
311
0.090
Why?
Combined Modality Therapy
2
2018
584
0.080
Why?
Radiation Dosage
1
2019
83
0.050
Why?
Postoperative Period
1
2018
85
0.050
Why?
Disease Management
1
2019
126
0.050
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
26
0.050
Why?
Radiometry
1
2017
42
0.050
Why?
Rats, Wistar
1
2017
112
0.050
Why?
Brain Death
1
2017
28
0.050
Why?
Confidence Intervals
1
2017
145
0.040
Why?
Clinical Trials as Topic
1
2019
335
0.040
Why?
Carcinoma, Renal Cell
1
2017
83
0.040
Why?
Incidence
1
2019
1142
0.040
Why?
Survival Analysis
1
2017
490
0.040
Why?
Analysis of Variance
1
2017
507
0.040
Why?
Perioperative Care
1
2015
64
0.040
Why?
Cohort Studies
1
2019
1724
0.040
Why?
Kidney Neoplasms
1
2017
145
0.040
Why?
Rats
1
2017
1845
0.030
Why?
Time Factors
1
2017
2144
0.030
Why?
United States
1
2018
3662
0.030
Why?
Breast Neoplasms
1
2017
761
0.030
Why?
Risk Factors
1
2017
3651
0.020
Why?
Animals
1
2017
7821
0.020
Why?
Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_